A pproximately 450,000 total joint arthroplasties are performed annually in the United States. Deep infections of these total joint replacements usually result in failure of the initial operation and the need for extensive revision. Owing to the use of perioperative antibiotic prophylaxis and other technical advances, deep infection occurring in the immediate postoperative period resulting from intraoperative contamination has been reduced markedly in the past 20 years.
Patients who are about to have a total joint arthroplasty should be in good dental health prior to surgery and should be encouraged to seek professional dental care if necessary. Patients who already have had a total joint arthroplasty should perform effective daily oral hygiene procedures to remove plaque (for example, by using manual or powered toothbrushes, interdental cleaners or oral irrigators) to establish and maintain good oral health. The risk of bacteremia is far more substantial in a mouth with ongoing inflammation than in one that is healthy and employing these home oral hygiene devices. 1 Bacteremias can cause hematogenous seeding of total joint implants, both in the early postoperative period and for many years following implantation. 2 It appears that the most critical period is up to two years after joint placement. 3 In addition, bacteremias may occur in Antibiotic prophylaxis is not routinely indicated for most dental patients with total joint r e p l a c e m e n t s .
the course of normal daily life 4-6 and concurrently with dental and medical procedures. 6 It is likely that many more oral bacteremias are spontaneously induced by daily events than are dental treatment-induced. 6 Presently, no scientific evidence supports the position that antibiotic prophylaxis to prevent hematogenous infections is required prior to dental treatment in patients with total joint prostheses. 1 The risk/benefit 7, 8 and cost/effectiveness 7,9 ratios fail to justify the administration of routine antibiotic prophylaxis. The analogy of late prosthetic joint infections with infective endocarditis is invalid, as the anatomy, blood supply, microorganisms and mechanisms of infection are all different. 10 It is likely that bacteremias associated with acute infection in the oral cavity, 11, 12 skin, respiratory, gastrointestinal and urogenital systems and/or other sites can and do cause late implant infection. 12 Any patient with a total joint prosthesis with acute orofacial infection should be vigorously treated as any other patient with elimination of the source of the infection (incision and drainage, endodontics, extraction) and appropriate therapeutic antibiotics when indicated. 1, 12 Practitioners should maintain a high index of suspicion for any unusual signs and symptoms (such as fever, swelling, pain, joint that is warm to touch) in patients with total joint prostheses.
Antibiotic prophylaxis is not indicated for dental patients with pins, plates and screws, nor is it routinely indicated for most dental patients with total joint replacements. This position agrees with that taken by the ADA Council on Dental Therapeutics 13 and the American Academy of Oral Medicine 14 and is similar to that taken by the British Society for Antimicrobial Chemotherapy. 15 There is limited evidence that some immunocompromised patients with total joint replacements ( Table 1 ) may be at higher risk of experiencing hematogenous infections. 12, [16] [17] [18] [19] [20] [21] [22] [23] Antibiotic prophylaxis for such patients undergoing dental procedures with a higher bacteremic risk (as defined in Table 2 ) should be considered using an empirical regimen (Table 3 ). In addition, antibiotic prophylaxis may be considered when the higher-risk dental procedures (again, as defined in Table 2 ) are performed on dental patients within two years post-implant surgery, 3 on those who have had previous prosthetic joint infections and on those with some other conditions (Table 1) .
Occasionally, a patient with a total joint prosthesis may present to the dentist with a recom-896 JADA, Vol. 134, July 2003 
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PATIENTS AT POTENTIAL INCREASED RISK OF EXPERIENCING HEMATOGENOUS TOTAL JOINT INFECTION.*
PATIENT TYPE CONDITION PLACING PATIENT AT RISK
* Based on Ching and colleagues, 12 Brause, 16 Murray and colleagues, 17 Poss and colleagues, 18 Jacobson and colleagues, 19 Johnson and Bannister, 20 Jacobson and colleagues 21 Any perceived potential benefit of antibiotic prophylaxis must be weighed against the known risks of antibiotic toxicity; allergy; and development, selection and transmission of microbial resistance. Insulin-dependent (type 1) diabetes Malignancy mendation from his or her physician that is not consistent with these guidelines. This could be due to lack of familiarity with the guidelines or to special considerations about the patient's medical condition that are not known to the dentist. In this situation, the dentist is encouraged to consult with the physician to determine if there are any special considerations that might affect the dentist's decision on whether or not to premedicate, and may wish to share a copy of these guidelines with the physician if appropriate. After this consultation, the dentist may decide to follow the 23 † Prophylaxis should be considered for patients with total joint replacement who meet the criteria in Table 1 . No other patients with orthopedic implants should be considered for antibiotic prophylaxis prior to dental treatment/procedures. ‡ Prophylaxis not indicated. § Clinical judgment may indicate antibiotic use in selected circumstances that may create significant bleeding. ¶ Includes restoration of carious (decayed) or missing teeth. physician's recommendation or, if in the dentist's professional judgment antibiotic prophylaxis is not indicated, may decide to proceed without antibiotic prophylaxis. The dentist is ultimately responsible for making treatment recommendations for his or her patients based on the dentist's professional judgment. Any perceived potential benefit of antibiotic prophylaxis must be weighed against the known risks of antibiotic toxicity; allergy; and development, selection and transmission of microbial resistance. This statement provides guidelines to supplement practitioners in their clinical judgment regarding antibiotic prophylaxis for dental patients with a total joint prosthesis. (Editor's note: The patient handout on page 899 can be duplicated to provide patients with an overview of these guidelines.) It is not intended as the standard of care nor as a substitute for clinical judgment, as it is impossible to make recommendations for all conceivable clinical situations in which bacteremias originating from the oral cavity may occur. Practitioners must exercise their own clinical judgment in determining whether or not antibiotic prophylaxis is appropriate. s Dentists and physicians are encouraged to reproduce the above Advisory Statement for distribution to colleagues. Permission to reprint the Advisory Statement is hereby granted by ADA and AAOS, provided that the Advisory Statement is reprinted in its entirety including citations and that such reprints contain a notice stating "Copyright © 2003 American Dental Association and American Academy of Orthopaedic Surgeons. Reprinted with permission." If you wish to use the Advisory Statement in any other fashion, written permission must be obtained from ADA and AAOS.
Your joint replacement, dental pro c e d u re s and antibiotics
AMERICAN DENTAL ASSOCIATION AND AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
F or the first two years after a joint replacement, all patients may need antibiotics for all high-risk dental procedures. After two years, only high-risk patients may need to receive antibiotics for high-risk procedures.
The bacteria commonly found in the mouth may travel through the bloodstream and settle in your artificial joint. This increases your risk of contracting an infection. Ask your dentist about preventive antibiotics for all dental procedures with a high risk of bleeding or producing high levels of bacteria in your blood. Your dentist and your orthopaedic surgeon, working together, will develop an appropriate course of treatment for you.
You may need preventive antibiotics before all high-risk dental procedures if dyou had a joint replacement less than two years ago. dyou've had previous infections in your artificial joint. dyou have an inflammatory type of arthritis, type 1 diabetes or hemophilia. dyou have a suppressed immune system or are malnourished. dyou have a history of prior or present malignancy.
These dental procedures have a high risk of bleeding or producing high levels of bacteria in your blood: dall dental extractions; dall periodontal procedures; ddental implant placement and replantation of teeth that were knocked out; dsome root canal work; dinitial placement of orthodontic bands (not brackets); dcertain specialized local anesthetic injections; dregular dental cleanings (if bleeding is anticipated).
One of these preventive antibiotics may be prescribed for you: dif you are not allergic to penicillin: 2 grams of amoxicillin, cephalexin or cephradine (orally) OR 2 grams of ampicillin or 1 gram of cefazolin (intramuscularly or intravenously) 1 hour before the procedure. dif you are allergic to penicillin: 600 milligrams of clindamycin (orally or intravenously) 1 hour before the procedure.
These guidelines were developed by the American Academy of Orthopaedic Surgeons and the American Dental Association. They are designed to help practitioners make decisions about preventive antibiotics for dental patients with artificial joints. They are not a standard of care or a substitute for the practitioner's clinical judgment. Practitioners must exercise their own clinical judgment in determining whether or not preventive antibiotics are appropriate. Pediatric doses may be different.
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